Cargando…

Targeted drug delivery for cancer therapy: the other side of antibodies

Therapeutic monoclonal antibody (TMA) based therapies for cancer have advanced significantly over the past two decades both in their molecular sophistication and clinical efficacy. Initial development efforts focused mainly on humanizing the antibody protein to overcome problems of immunogenicity an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Firer, Michael A, Gellerman, Gary
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3508879/ https://www.ncbi.nlm.nih.gov/pubmed/23140144 http://dx.doi.org/10.1186/1756-8722-5-70

Ejemplares similares

Recent Innovations in Peptide Based Targeted Drug Delivery to Cancer Cells
por: Gilad, Yosi, et al.
Publicado: (2016)

Gold nanoparticles stabilize peptide-drug-conjugates for sustained targeted drug delivery to cancer cells
por: Kalimuthu, Kalishwaralal, et al.
Publicado: (2018)

Novel Cyclic Peptides for Targeting EGFR and EGRvIII Mutation for Drug Delivery
por: Furman, Olga, et al.
Publicado: (2022)

Theranostic system for ratiometric fluorescence monitoring of peptide-guided targeted drug delivery
por: Rozovsky, Alex, et al.
Publicado: (2019)

The Other Side of Plastics: Bioplastic-Based Nanoparticles for Drug Delivery Systems in the Brain
por: Lamparelli, Erwin Pavel, et al.
Publicado: (2023)

Drug Combination in Cancer Treatment—From Cocktails to Conjugated Combinations
por: Gilad, Yosi, et al.
Publicado: (2021)

Development, efficacy and side effects of antibody‑drug conjugates for cancer therapy (Review)
por: Sun, Te, et al.
Publicado: (2023)

Sequential Drug Delivery in Targeted Cancer Therapy
por: Yu, Han, et al.
Publicado: (2022)

Antibody-based drug delivery systems for cancer therapy: Mechanisms, challenges, and prospects
por: Chen, Zhoujiang, et al.
Publicado: (2022)

Review targeted drug delivery systems for norcantharidin in cancer therapy
por: Zhai, Bing-Tao, et al.
Publicado: (2022)

Extracellular Vesicles as Drug Targets and Delivery Vehicles for Cancer Therapy
por: Chitti, Sai V., et al.
Publicado: (2022)

Aptamers as Smart Ligands for Targeted Drug Delivery in Cancer Therapy
por: Wei, Zongyi, et al.
Publicado: (2022)

Targeted Drug Delivery Systems for Curcumin in Breast Cancer Therapy
por: Huang, Mian, et al.
Publicado: (2023)

Antibody-conjugated nanoparticles for target-specific drug delivery of chemotherapeutics
por: Kumari, Mamta, et al.
Publicado: (2023)

Antibody Based Delivery of Toxins and Other Active Molecules for Cancer Therapy
por: Polito, Letizia
Publicado: (2022)

Advances in Targeted Therapy of Breast Cancer with Antibody-Drug Conjugate
por: Subhan, Md Abdus, et al.
Publicado: (2023)

Glycans as Targets for Drug Delivery in Cancer
por: Diniz, Francisca, et al.
Publicado: (2022)

Targeted Delivery of Drugs and Genes Using Polymer Nanocarriers for Cancer Therapy
por: Xia, Wentao, et al.
Publicado: (2021)

Recent Advancements in Mitochondria-Targeted Nanoparticle Drug Delivery for Cancer Therapy
por: Xu, Jiangsheng, et al.
Publicado: (2022)

Overview of Antibody Drug Delivery
por: Awwad, Sahar, et al.
Publicado: (2018)

Antibody drug conjugate: the “biological missile” for targeted cancer therapy
por: Fu, Zhiwen, et al.
Publicado: (2022)

The Other Side of the Opium Question
Publicado: (1882)

Extracellular vesicles as novel drug delivery systems to target cancer and other diseases: Recent advancements and future perspectives
por: Ramesh, Divya, et al.
Publicado: (2023)

Antibody-Drug Conjugates and Targeted Treatment Strategies for Hepatocellular Carcinoma: A Drug-Delivery Perspective
por: Dahlgren, David, et al.
Publicado: (2020)

The application of carbon nanotubes in target drug delivery systems for cancer therapies
por: Zhang, Wuxu, et al.
Publicado: (2011)

Nanoparticle-Mediated Targeted Drug Delivery to Remodel Tumor Microenvironment for Cancer Therapy
por: Tang, Lu, et al.
Publicado: (2021)

Advanced MXene-Based Micro- and Nanosystems for Targeted Drug Delivery in Cancer Therapy
por: Mohajer, Fatemeh, et al.
Publicado: (2022)

Nano-Drug Delivery Systems Based on Different Targeting Mechanisms in the Targeted Therapy of Colorectal Cancer
por: Wang, Ke, et al.
Publicado: (2022)

Targeted Microbubbles for Drug, Gene, and Cell Delivery in Therapy and Immunotherapy
por: Navarro-Becerra, J. Angel, et al.
Publicado: (2023)

Her-2 Targeted Therapy in Advanced Urothelial Cancer: From Monoclonal Antibodies to Antibody-Drug Conjugates
por: Albarrán, Víctor, et al.
Publicado: (2022)

Target Nanoparticles against Pancreatic Cancer: Fewer Side Effects in Therapy
por: Roacho-Pérez, Jorge A., et al.
Publicado: (2021)

Targeted Drug Delivery for the Treatment of Blood Cancers
por: Jiang, Yao, et al.
Publicado: (2022)

Carrageenan: Drug Delivery Systems and Other Biomedical Applications
por: Pacheco-Quito, Edisson-Mauricio, et al.
Publicado: (2020)

Antibody–Drug Conjugates for Cancer Therapy
por: Parslow, Adam C., et al.
Publicado: (2016)

Antibody–Drug Conjugates for Cancer Therapy
por: Hafeez, Umbreen, et al.
Publicado: (2020)

Recent Progress in Extracellular Vesicle-Based Carriers for Targeted Drug Delivery in Cancer Therapy
por: Tang, Yaqin, et al.
Publicado: (2023)

Delivery strategies for macromolecular drugs in cancer therapy
por: Guo, Qin, et al.
Publicado: (2020)

The Other Side of Cocaine—The Bad Side
por: Calhoun, A. W.
Publicado: (1886)

New drugs, new toxicities: severe side effects of modern targeted and immunotherapy of cancer and their management
por: Kroschinsky, Frank, et al.
Publicado: (2017)

Multifunctional Nanomaterials and Their Applications in Drug Delivery and Cancer Therapy
por: Srinivasan, Mathangi, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_10ej3l9ajnpch0u4ohhtofn7lb